Yingjie Lai

Title: Yingjie Lai: Innovator in Pharmaceutical Compounds

Introduction

Yingjie Lai is a prominent inventor based in Cupertino, CA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on innovative compounds and their therapeutic applications.

Latest Patents

One of Yingjie Lai's latest patents is titled "Pyrazolopyridine compounds, compositions and methods of use." This invention provides compounds of Formula I, including stereoisomers or pharmaceutically acceptable salts. The patent describes a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant, or vehicle. Additionally, it outlines methods for using the compound or composition in therapy. Another notable patent involves compounds of Formula I, where certain components are optionally substituted thiadiazolyl. The methods disclosed in this patent are aimed at treating diseases associated with P2X and/or P2X receptor antagonists.

Career Highlights

Yingjie Lai has worked with notable companies in the pharmaceutical industry, including Roche Palo Alto LLC and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Yingjie has collaborated with esteemed colleagues such as Simon Charles Goodacre and Jun Liang. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Yingjie Lai is a distinguished inventor whose work in pharmaceutical compounds has led to several patents and innovative solutions. His contributions continue to impact the field positively.